Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

DeepSeek claims it can reduce the power consumption of AI, urging the energy industry to rethink future demand estimates.

ALBANY — Gov. Kathy Hochul is proposing to increase access to popular diabetes medications such as Wegovy and Ozempic for use as weight-loss drugs by Medicaid, while lowering their high cost ...

Since 2022, the company has seen its share price increase by over 150% due to the explosive demand for its weight loss (Wegovy) and diabetes (Ozempic) drugs. However, since mid-2024, the sentiment ...

Wegovy's patent expiration is also remote ... but also creates the basis for future growth. The below chart suggests that innovation has consistently been the core of NVO's long-term strategy ...

Harry Styles brings Harry's House back to two charts in the U.K. this week, doubling the number of ... [+] rankings it appears on in the superstar's home country. LOS ANGELES, CALIFORNIA ...

On Jan. 1, North Dakota became the first state in the country where access to drugs like Wegovy is part of the EHB package. About 55,293 of North Dakota's 784,000 residents had coverage through ...

An estimated 3.4 million Brits meet the criteria to receive a prescription for Wegovy and Mounjaro which would cost £10billion a year. All weight loss jabs, including Ozempic, contain semaglutide ...

There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, according to the chief executive officer of Zealand Pharma A/S ...

He said he felt "blessed" to be given the drug. But the NHS spending watchdog NICE has ruled that each patient can only receive Wegovy for two years. And only a tiny proportion of the eligible 3.4 ...